View Future GrowthDeepak Chemtex 과거 순이익 실적과거 기준 점검 4/6Deepak Chemtex은 연평균 26%의 비율로 수입이 증가해 온 반면, Chemicals 산업은 수입이 6.7% 증가했습니다. 매출은 연평균 7.4%의 비율로 증가했습니다. Deepak Chemtex의 자기자본이익률은 18.7%이고 순이익률은 15.4%입니다.핵심 정보26.02%순이익 성장률19.76%주당순이익(EPS) 성장률Chemicals 산업 성장률17.68%매출 성장률7.35%자기자본이익률18.70%순이익률15.42%다음 순이익 업데이트29 May 2026최근 과거 실적 업데이트공시 • 20hDeepak Chemtex Limited to Report Second Half, 2026 Results on May 29, 2026Deepak Chemtex Limited announced that they will report second half, 2026 results on May 29, 2026공시 • Nov 05Deepak Chemtex Limited to Report First Half, 2026 Results on Nov 14, 2025Deepak Chemtex Limited announced that they will report first half, 2026 results on Nov 14, 2025Reported Earnings • Sep 04Full year 2025 earnings released: EPS: ₹11.38 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.38 (up from ₹6.71 in FY 2024). Revenue: ₹797.0m (up 60% from FY 2024). Net income: ₹123.6m (up 107% from FY 2024). Profit margin: 16% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.Reported Earnings • Jun 02Full year 2025 earnings released: EPS: ₹11.69 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.69 (up from ₹6.71 in FY 2024). Revenue: ₹819.5m (up 65% from FY 2024). Net income: ₹125.1m (up 109% from FY 2024). Profit margin: 15% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.공시 • May 16Deepak Chemtex Limited to Report Q4, 2025 Results on May 30, 2025Deepak Chemtex Limited announced that they will report Q4, 2025 results on May 30, 2025공시 • Nov 09Deepak Chemtex Limited to Report First Half, 2025 Results on Nov 14, 2024Deepak Chemtex Limited announced that they will report first half, 2025 results on Nov 14, 2024모든 업데이트 보기Recent updates공시 • 20hDeepak Chemtex Limited to Report Second Half, 2026 Results on May 29, 2026Deepak Chemtex Limited announced that they will report second half, 2026 results on May 29, 2026New Risk • May 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹956.0m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹956.0m market cap, or US$9.92m). Minor Risk Share price has been volatile over the past 3 months (9.6% average weekly change).Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹92.80, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 20% over the past year.New Risk • Apr 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹869.0m market cap, or US$9.31m). Minor Risk Share price has been volatile over the past 3 months (8.5% average weekly change).Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹71.20, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 35% over the past year.New Risk • Mar 16New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹903.3m (US$9.79m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹903.3m market cap, or US$9.79m).Valuation Update With 7 Day Price Move • Nov 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹113, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 13% over the past year.공시 • Nov 05Deepak Chemtex Limited to Report First Half, 2026 Results on Nov 14, 2025Deepak Chemtex Limited announced that they will report first half, 2026 results on Nov 14, 2025Reported Earnings • Sep 04Full year 2025 earnings released: EPS: ₹11.38 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.38 (up from ₹6.71 in FY 2024). Revenue: ₹797.0m (up 60% from FY 2024). Net income: ₹123.6m (up 107% from FY 2024). Profit margin: 16% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.공시 • Aug 26Deepak Chemtex Limited, Annual General Meeting, Sep 22, 2025Deepak Chemtex Limited, Annual General Meeting, Sep 22, 2025, at 15:00 Indian Standard Time.Valuation Update With 7 Day Price Move • Jul 29Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹162, the stock trades at a trailing P/E ratio of 14.1x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 68% over the past year.공시 • Jul 28Deepak Chemtex Limited Announces Cessation of Directors with Effect from July 27, 2025The Board of Directors of Deepak Chemtex Limited approved that Mr. Gautam Lath (DIN: 10198794) have completed his term as Independent Director and consequently, ceased to be the Independent Director of the Company with effect from the close of business hours on July 27, 2025 and Mrs. Pinki Kedia (DIN: 08455451) have completed her term as Independent Director and consequently, ceased to be the Independent Director of the Company with effect from the close of business hours on July 27, 2025.Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹149, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 69% over the past year.New Risk • Jun 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.8% average weekly change). High level of non-cash earnings (48% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.52b market cap, or US$17.8m).Reported Earnings • Jun 02Full year 2025 earnings released: EPS: ₹11.69 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.69 (up from ₹6.71 in FY 2024). Revenue: ₹819.5m (up 65% from FY 2024). Net income: ₹125.1m (up 109% from FY 2024). Profit margin: 15% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.공시 • May 16Deepak Chemtex Limited to Report Q4, 2025 Results on May 30, 2025Deepak Chemtex Limited announced that they will report Q4, 2025 results on May 30, 2025Valuation Update With 7 Day Price Move • Feb 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹101, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 1.7% over the past year.Valuation Update With 7 Day Price Move • Dec 24Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹144, the stock trades at a trailing P/E ratio of 18.4x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 25% over the past year.New Risk • Dec 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (64% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₹1.78b market cap, or US$21.0m).Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹164, the stock trades at a trailing P/E ratio of 20.9x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 25% over the past year.Valuation Update With 7 Day Price Move • Nov 12Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹120, the stock trades at a trailing P/E ratio of 21.9x. Average trailing P/E is 34x in the Chemicals industry in India.공시 • Nov 09Deepak Chemtex Limited to Report First Half, 2025 Results on Nov 14, 2024Deepak Chemtex Limited announced that they will report first half, 2025 results on Nov 14, 2024공시 • Aug 30Deepak Chemtex Limited, Annual General Meeting, Sep 25, 2024Deepak Chemtex Limited, Annual General Meeting, Sep 25, 2024.Valuation Update With 7 Day Price Move • Jul 04Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹97.15, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 34x in the Chemicals industry in India.Reported Earnings • Jun 05Full year 2024 earnings released: EPS: ₹6.73 (vs ₹7.90 in FY 2023)Full year 2024 results: EPS: ₹6.73 (down from ₹7.90 in FY 2023). Revenue: ₹505.4m (up 8.2% from FY 2023). Net income: ₹60.0m (down 5.0% from FY 2023). Profit margin: 12% (down from 14% in FY 2023). The decrease in margin was driven by higher expenses.Valuation Update With 7 Day Price Move • May 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹105, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 30x in the Chemicals industry in India.공시 • May 17Deepak Chemtex Limited to Report Second Half, 2024 Results on May 22, 2024Deepak Chemtex Limited announced that they will report second half, 2024 results on May 22, 2024Valuation Update With 7 Day Price Move • Apr 18Investor sentiment improves as stock rises 32%After last week's 32% share price gain to ₹104, the stock trades at a trailing P/E ratio of 17.8x. Average trailing P/E is 30x in the Chemicals industry in India.New Risk • Apr 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 14% over the past year. High level of non-cash earnings (37% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported March 2023 fiscal period end). Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₹937.5m market cap, or US$11.2m).Valuation Update With 7 Day Price Move • Apr 02Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹81.00, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 29x in the Chemicals industry in India.Buying Opportunity • Dec 14Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be ₹151, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 14% over the last year. Earnings per share has grown by 49%.Board Change • Dec 06Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Pinki Kedia was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.매출 및 비용 세부 내역Deepak Chemtex가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이BSE:544036 매출, 비용 및 순이익 (INR Millions)날짜매출순이익일반관리비연구개발비30 Sep 2571811157030 Jun 2575711755031 Mar 2579712453031 Dec 2473310446030 Sep 246688543030 Jun 245837239031 Mar 244976035031 Mar 234676127031 Mar 225414224031 Mar 2129626190양질의 수익: 544036의 비현금 수익 수준이 높습니다.이익 마진 증가: 544036의 현재 순 이익률 (15.4%)은 지난해 (12.7%)보다 높습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 544036의 수익은 지난 5년 동안 연평균 26%로 크게 증가했습니다.성장 가속화: 지난 1년간 544036 의 수익 증가율(30.3%)은 연간 평균(26%)을 초과합니다.수익 대 산업: 544036의 지난 1년 수익 증가율(30.3%)은 Chemicals 업계의 10.1%를 상회했습니다.자기자본이익률높은 ROE: 544036의 자본 수익률(18.7%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/22 04:12종가2026/05/22 00:00수익2025/09/30연간 수익2025/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스Deepak Chemtex Limited는 0명의 분석가가 다루고 있습니다. 이 중 0명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • 20hDeepak Chemtex Limited to Report Second Half, 2026 Results on May 29, 2026Deepak Chemtex Limited announced that they will report second half, 2026 results on May 29, 2026
공시 • Nov 05Deepak Chemtex Limited to Report First Half, 2026 Results on Nov 14, 2025Deepak Chemtex Limited announced that they will report first half, 2026 results on Nov 14, 2025
Reported Earnings • Sep 04Full year 2025 earnings released: EPS: ₹11.38 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.38 (up from ₹6.71 in FY 2024). Revenue: ₹797.0m (up 60% from FY 2024). Net income: ₹123.6m (up 107% from FY 2024). Profit margin: 16% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.
Reported Earnings • Jun 02Full year 2025 earnings released: EPS: ₹11.69 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.69 (up from ₹6.71 in FY 2024). Revenue: ₹819.5m (up 65% from FY 2024). Net income: ₹125.1m (up 109% from FY 2024). Profit margin: 15% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.
공시 • May 16Deepak Chemtex Limited to Report Q4, 2025 Results on May 30, 2025Deepak Chemtex Limited announced that they will report Q4, 2025 results on May 30, 2025
공시 • Nov 09Deepak Chemtex Limited to Report First Half, 2025 Results on Nov 14, 2024Deepak Chemtex Limited announced that they will report first half, 2025 results on Nov 14, 2024
공시 • 20hDeepak Chemtex Limited to Report Second Half, 2026 Results on May 29, 2026Deepak Chemtex Limited announced that they will report second half, 2026 results on May 29, 2026
New Risk • May 21New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹956.0m (US$9.92m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹956.0m market cap, or US$9.92m). Minor Risk Share price has been volatile over the past 3 months (9.6% average weekly change).
Valuation Update With 7 Day Price Move • Apr 11Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹92.80, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 21x in the Chemicals industry in India. Total loss to shareholders of 20% over the past year.
New Risk • Apr 01New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹869.0m market cap, or US$9.31m). Minor Risk Share price has been volatile over the past 3 months (8.5% average weekly change).
Valuation Update With 7 Day Price Move • Mar 27Investor sentiment deteriorates as stock falls 17%After last week's 17% share price decline to ₹71.20, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 20x in the Chemicals industry in India. Total loss to shareholders of 35% over the past year.
New Risk • Mar 16New major risk - Market cap sizeThe company's market capitalization is less than US$10m. Market cap: ₹903.3m (US$9.79m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks High level of non-cash earnings (46% accrual ratio). Market cap is less than US$10m (₹903.3m market cap, or US$9.79m).
Valuation Update With 7 Day Price Move • Nov 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹113, the stock trades at a trailing P/E ratio of 10x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 13% over the past year.
공시 • Nov 05Deepak Chemtex Limited to Report First Half, 2026 Results on Nov 14, 2025Deepak Chemtex Limited announced that they will report first half, 2026 results on Nov 14, 2025
Reported Earnings • Sep 04Full year 2025 earnings released: EPS: ₹11.38 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.38 (up from ₹6.71 in FY 2024). Revenue: ₹797.0m (up 60% from FY 2024). Net income: ₹123.6m (up 107% from FY 2024). Profit margin: 16% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.
공시 • Aug 26Deepak Chemtex Limited, Annual General Meeting, Sep 22, 2025Deepak Chemtex Limited, Annual General Meeting, Sep 22, 2025, at 15:00 Indian Standard Time.
Valuation Update With 7 Day Price Move • Jul 29Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹162, the stock trades at a trailing P/E ratio of 14.1x. Average trailing P/E is 29x in the Chemicals industry in India. Total returns to shareholders of 68% over the past year.
공시 • Jul 28Deepak Chemtex Limited Announces Cessation of Directors with Effect from July 27, 2025The Board of Directors of Deepak Chemtex Limited approved that Mr. Gautam Lath (DIN: 10198794) have completed his term as Independent Director and consequently, ceased to be the Independent Director of the Company with effect from the close of business hours on July 27, 2025 and Mrs. Pinki Kedia (DIN: 08455451) have completed her term as Independent Director and consequently, ceased to be the Independent Director of the Company with effect from the close of business hours on July 27, 2025.
Valuation Update With 7 Day Price Move • Jun 06Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹149, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 69% over the past year.
New Risk • Jun 02New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.8% average weekly change). High level of non-cash earnings (48% accrual ratio). Minor Risk Market cap is less than US$100m (₹1.52b market cap, or US$17.8m).
Reported Earnings • Jun 02Full year 2025 earnings released: EPS: ₹11.69 (vs ₹6.71 in FY 2024)Full year 2025 results: EPS: ₹11.69 (up from ₹6.71 in FY 2024). Revenue: ₹819.5m (up 65% from FY 2024). Net income: ₹125.1m (up 109% from FY 2024). Profit margin: 15% (up from 12% in FY 2024). The increase in margin was driven by higher revenue.
공시 • May 16Deepak Chemtex Limited to Report Q4, 2025 Results on May 30, 2025Deepak Chemtex Limited announced that they will report Q4, 2025 results on May 30, 2025
Valuation Update With 7 Day Price Move • Feb 17Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹101, the stock trades at a trailing P/E ratio of 12.9x. Average trailing P/E is 25x in the Chemicals industry in India. Total loss to shareholders of 1.7% over the past year.
Valuation Update With 7 Day Price Move • Dec 24Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to ₹144, the stock trades at a trailing P/E ratio of 18.4x. Average trailing P/E is 32x in the Chemicals industry in India. Total returns to shareholders of 25% over the past year.
New Risk • Dec 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (64% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₹1.78b market cap, or US$21.0m).
Valuation Update With 7 Day Price Move • Dec 10Investor sentiment improves as stock rises 28%After last week's 28% share price gain to ₹164, the stock trades at a trailing P/E ratio of 20.9x. Average trailing P/E is 33x in the Chemicals industry in India. Total returns to shareholders of 25% over the past year.
Valuation Update With 7 Day Price Move • Nov 12Investor sentiment improves as stock rises 24%After last week's 24% share price gain to ₹120, the stock trades at a trailing P/E ratio of 21.9x. Average trailing P/E is 34x in the Chemicals industry in India.
공시 • Nov 09Deepak Chemtex Limited to Report First Half, 2025 Results on Nov 14, 2024Deepak Chemtex Limited announced that they will report first half, 2025 results on Nov 14, 2024
공시 • Aug 30Deepak Chemtex Limited, Annual General Meeting, Sep 25, 2024Deepak Chemtex Limited, Annual General Meeting, Sep 25, 2024.
Valuation Update With 7 Day Price Move • Jul 04Investor sentiment improves as stock rises 20%After last week's 20% share price gain to ₹97.15, the stock trades at a trailing P/E ratio of 17.7x. Average trailing P/E is 34x in the Chemicals industry in India.
Reported Earnings • Jun 05Full year 2024 earnings released: EPS: ₹6.73 (vs ₹7.90 in FY 2023)Full year 2024 results: EPS: ₹6.73 (down from ₹7.90 in FY 2023). Revenue: ₹505.4m (up 8.2% from FY 2023). Net income: ₹60.0m (down 5.0% from FY 2023). Profit margin: 12% (down from 14% in FY 2023). The decrease in margin was driven by higher expenses.
Valuation Update With 7 Day Price Move • May 21Investor sentiment improves as stock rises 17%After last week's 17% share price gain to ₹105, the stock trades at a trailing P/E ratio of 18.1x. Average trailing P/E is 30x in the Chemicals industry in India.
공시 • May 17Deepak Chemtex Limited to Report Second Half, 2024 Results on May 22, 2024Deepak Chemtex Limited announced that they will report second half, 2024 results on May 22, 2024
Valuation Update With 7 Day Price Move • Apr 18Investor sentiment improves as stock rises 32%After last week's 32% share price gain to ₹104, the stock trades at a trailing P/E ratio of 17.8x. Average trailing P/E is 30x in the Chemicals industry in India.
New Risk • Apr 17New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended March 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue has declined by 14% over the past year. High level of non-cash earnings (37% accrual ratio). Minor Risks Latest financial reports are more than 6 months old (reported March 2023 fiscal period end). Share price has been volatile over the past 3 months (8.8% average weekly change). Market cap is less than US$100m (₹937.5m market cap, or US$11.2m).
Valuation Update With 7 Day Price Move • Apr 02Investor sentiment improves as stock rises 18%After last week's 18% share price gain to ₹81.00, the stock trades at a trailing P/E ratio of 13.9x. Average trailing P/E is 29x in the Chemicals industry in India.
Buying Opportunity • Dec 14Now 22% undervaluedThe stock has been flat over the last 90 days. The fair value is estimated to be ₹151, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 14% over the last year. Earnings per share has grown by 49%.
Board Change • Dec 06Less than half of directors are independentFollowing the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 4 non-independent directors. Independent Director Pinki Kedia was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.